Concentration of heavy metals and rare earth elements in patients with brain tumours: Analysis in tumour tissue, non-tumour tissue, and blood.
Laura GamanMugurel Petrinel RadoiCorina Elena DeliaOctavio P LuzardoManuel ZumbadoÁngel Rodríguez-HernándezIrina StoianMarilena GilcaLuis D BoadaLuis Alberto Henríquez-HernándezPublished in: International journal of environmental health research (2019)
Inorganic elements have been associated with brain tumours for long. The blood concentration of 47 elements was assessed by ICP-MS in 26 brain tumour patients and 21 healthy subjects from Bucharest (Romania). All 47 elements were detected in the brain tumour tissue, and 22 were detected in > 80% of samples; this implies that these elements can cross the blood-brain barrier. Median blood levels of cadmium, lead, and nickel were higher than the reference values (1.14, 53.3, and 2.53 ng/mL). Gadolinium and tantalum showed significantly higher concentrations among cases. We observed considerable differences and different profiles of the presence of inorganic elements between the tumour and non-tumour brain tissue and between tissue from the primary tumour and tissue from brain metastasis. Our data suggest that similar to heavy metals, other elements - commonly used in high tech devices and rare earth elements - can also influence brain tumour.
Keyphrases
- resting state
- white matter
- heavy metals
- functional connectivity
- end stage renal disease
- cerebral ischemia
- multiple sclerosis
- chronic kidney disease
- risk assessment
- peritoneal dialysis
- newly diagnosed
- ms ms
- magnetic resonance imaging
- magnetic resonance
- machine learning
- prognostic factors
- health risk assessment
- subarachnoid hemorrhage
- water soluble
- brain injury
- patient reported
- perovskite solar cells